Ultimately, ADH4, DHRS3, DHRS9, LRAT, RDH10, RDH12, and RDH5 were selected as prognostic genes for building an RA metabolism–related prognostic signature with glioma. This evidence concerns the gene DHRS3 and central nervous system cancer.